The frequency of co-infections with bacterial or fungal pathogens has constantly increased
among critically ill patients with coronavirus disease 2019 (COVID-19) during the pandemic …

Importance Efforts to quantify the burden of SARS-CoV-2–associated sepsis have been
limited by inconsistent definitions and underrecognition of viral sepsis. Objective To describe …

Abstract Purpose of Review Since the end of 2019, the coronavirus disease 2019 (COVID-
19) pandemic has infected nearly 800 million people and caused almost seven million …

The SARS-CoV-2 pandemic caused an increase in intensive care unit (ICU) hospitalizations
with a rise in morbidity and mortality; nevertheless, there is still little evidence on the impact …

Background Ventilator-associated pneumonia (VAP) is common in patients with severe
SARS-CoV-2 pneumonia. The aim of this ancillary analysis of the coVAPid multicenter …

A bloodstream infection (BSI) is a severe ICU-acquired infection. A growing proportion is
caused by multidrug-resistant bacteria (MDRB). COVID-19 was reported to be associated …

Background Diagnosing COVID-19-associated pulmonary aspergillosis (CAPA) can be
challenging since radiological and clinical criteria in the critically ill patient are nonspecific …

Objective To evaluate the implementation of an antibiotic stewardship program in critically ill
COVID-19 patients and to establish risk factors for coinfection. Secondary objective was to …

Background: Nearly 10% of COVID-19 cases will require admission to the intensive care unit
(ICU). Our aim was to assess the clinical and microbiological outcomes of secondary …

The development of secondary bacterial infections in COVID-19 patients has been
associated with increased mortality and worse clinical outcomes. Consequently, many …